Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DBVT

DBV Technologies

$43.85

0.04 (0.09%)

, AIMT

Aimmune

$23.17

-0.05 (-0.22%)

05:46
09/12/17
09/12
05:46
09/12/17
05:46
Recommendations
DBV Technologies, Aimmune analyst commentary at Jefferies »

Jefferies allergist poll…

DBVT

DBV Technologies

$43.85

0.04 (0.09%)

AIMT

Aimmune

$23.17

-0.05 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 13

    Sep

  • 25

    Sep

DBVT

DBV Technologies

$43.28

-1.08 (-2.43%)

, AIMT

Aimmune

$21.72

0.06 (0.28%)

13:46
09/07/17
09/07
13:46
09/07/17
13:46
Hot Stocks
FDA, for first time, recognizes health claim to prevent a food allergy »

FDA Commissioner Scott…

DBVT

DBV Technologies

$43.28

-1.08 (-2.43%)

AIMT

Aimmune

$21.72

0.06 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

  • 11

    Sep

  • 25

    Sep

DBVT

DBV Technologies

$44.40

-1.36 (-2.97%)

08:36
08/25/17
08/25
08:36
08/25/17
08:36
Recommendations
DBV Technologies analyst commentary at Leerink »

DBV Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

Over a month ago
DBVT

DBV Technologies

$43.43

0.53 (1.24%)

05:29
08/17/17
08/17
05:29
08/17/17
05:29
Recommendations
DBV Technologies analyst commentary at Jefferies »

Expert sees positive DBV…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$44.24

0.44 (1.00%)

04:55
07/25/17
07/25
04:55
07/25/17
04:55
Conference/Events
DBV Technologies management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

DBVT

DBV Technologies

$43.80

-0.4 (-0.90%)

04:55
07/24/17
07/24
04:55
07/24/17
04:55
Conference/Events
DBV Technologies management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

DBVT

DBV Technologies

$44.20

0.96 (2.22%)

07:59
07/21/17
07/21
07:59
07/21/17
07:59
Conference/Events
DBV Technologies management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

Over a quarter ago
DBVT

DBV Technologies

$35.87

0.93 (2.66%)

07:30
06/23/17
06/23
07:30
06/23/17
07:30
Initiation
DBV Technologies initiated at Deutsche Bank »

DBV Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$33.20

0.01 (0.03%)

09:06
06/01/17
06/01
09:06
06/01/17
09:06
Upgrade
DBV Technologies rating change  »

DBV Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

DBVT

DBV Technologies

$34.87

0.27 (0.78%)

16:49
03/30/17
03/30
16:49
03/30/17
16:49
Hot Stocks
DBV reports Phase 1 data on Viaskin rPT, says found 'limitations' in design »

DBV Technologies, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.